Only 55% of the Public Trust the Efficacy of the Government's COVID-19 Vaccine

Consumer Services & Health

Lite

Dimas Jarot Bayu 25/12/2020 12:38 WIB

URL has been copied

Memuat...

Public trust in the efficacy of this vaccine has decreased compared to previous surveys.

Public Confidence in the Efficacy of the Government's COVID-19 Vaccine

A Font Kecil
A Font Sedang
A Font Besar

Access single data

Only 55% of the Public Trust the Efficacy of the Government's COVID-19 Vaccine

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Public Confidence in the Efficacy of the Government's COVID-19 Vaccine

Download

Source

A Small Font
A Medium Font
A Bigger Font

The latest survey by Saiful Mujani Research and Consulting (SMRC) shows that only 55% of Indonesians believe the government-provided vaccine can provide immunity against the Covid-19 coronavirus. Meanwhile, 21% of respondents do not believe that the government's vaccine can provide immunity from the coronavirus.

Public trust in the vaccine's efficacy has decreased compared to the previous survey. From December 9-12, 2020, 62% of people believed that the government's coronavirus vaccine could provide immunity. Only 17% of respondents did not believe this.

SMRC conducted a random telephone survey of 1,202 respondents from December 16-19, 2020. The survey has a margin of error of ±2.9% with a 95% confidence level.

The government continues to urge the public to implement the 3M movement (washing hands with soap, maintaining distance from crowds, and wearing masks) to prevent the spread of the coronavirus.

Editor : Muhammad Ahsan Ridhoi

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."